NCT04182958View on ClinicalTrials.gov

A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 25, 2019

Primary Completion Date

December 19, 2019

Study Completion Date

December 19, 2019

Conditions
Healthy Adult Male
Interventions
DRUG

(14C)-OPC-61815

On the morning of Day 1, all subjects will receive a single IV infusion of (14C) OPC-61815

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd, Leeds

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY